Comment on: ‘NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence’

被引：0

作者：

Livio Garattini

Nicholas Freemantle

机构：

[1] Institute for Pharmacological Research Mario Negri IRCCS,Centre for Health Economics

[2] University College London,Institute of Clinical Trials and Methodology

来源：

PharmacoEconomics | 2020年 / 38卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：121 / 122

页数：1

共 50 条

[1] Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'
Garattini, Livio
Freemantle, Nicholas
PHARMACOECONOMICS, 2020, 38 (01) : 121 - 122
[2] NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence
Bullement, Ash
Taylor, Matthew
McMordie, Sam Thomas
Waters, Errol
Hatswell, Anthony James
PHARMACOECONOMICS, 2019, 37 (11) : 1383 - 1390
[3] NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence
Ash Bullement
Matthew Taylor
Sam Thomas McMordie
Errol Waters
Anthony James Hatswell
PharmacoEconomics, 2019, 37 : 1383 - 1390
[4] REVIEW OF POSSIBLE CAUSES OF VARIATION IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS
Ling, C.
Nuabor, W.
Lyall, M.
Stevenson, A.
VALUE IN HEALTH, 2018, 21 : S200 - S200
[5] REVIEW OF POSSIBLE CAUSES OF VARIATION IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS
Ling, C.
Nuabor, W.
Lyall, M.
Stevenson, A.
VALUE IN HEALTH, 2018, 21 : S200 - S200
[6] Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals
Tosh, Jonathan C.
Longworth, Louise J.
George, Elisabeth
VALUE IN HEALTH, 2011, 14 (01) : 102 - 109
[7] WHAT IS THE ROLE OF THE COMPANY EVIDENCE SUBMISSION IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) MULTIPLE TECHNOLOGY APPRAISALS?
Pearson, I
Stevenson, A.
Krieger, T.
Ling, C.
VALUE IN HEALTH, 2019, 22 : S723 - S723
[8] MANAGED ACCESS AGREEMENTS (MAAS) IN APPRAISALS CONDUCTED BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
Balman, E.
Marshall, J. D.
VALUE IN HEALTH, 2017, 20 (09) : A704 - A704
[9] UTILITY VALUES USED IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS OF MEDICINES FOR 4 METASTATIC CANCERS
Burke, M. J.
Sidhu, R.
George, E.
VALUE IN HEALTH, 2013, 16 (07) : A420 - A420
[10] THE INCLUSION OF CAREGIVER BURDEN IN THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) HEALTH TECHNOLOGY APPRAISALS (HTAS) OF TREATMENTS FOR MENTAL HEALTH DISORDERS
Spencer, C.
Gillies, H.
Bentley, A.
VALUE IN HEALTH, 2023, 26 (12) : S378 - S378

← 1 2 3 4 5 →